Endotracheal Tubes Articles & Analysis
6 news found
N8 Medical, LLC (N8 Medical) today announced its first-in-human clinical trials of its flagship CeraShield™ endotracheal tube (CeraShield™ ETT) for intensive care unit patients expected to require mechanical ventilation for more than 48 hours. N8 Medical is encouraged by preliminary study data and believes that the CeraShield™ ETT will ...
Mr. Bracken added “Most endotracheal tubes are made of plastic. COVID-19 patients who become mechanically ventilated will require use of one of these plastic tubes to connect to the mechanical ventilator.” Ordinary endotracheal tubes lack any antifouling protection. Within hours, these ...
In parallel, an application was made to the FDA for Emergency Use Authorization to employ aerFree® as an aid to intubation in patients with COVID-19. aerFree® may play an important role in this setting given its ease of use and its ability to expand the caliber of the upper airway, thereby facilitating first pass placement of endotracheal tubes and ...
In contrast, conventional endotracheal tubes allow pathogenic bacteria to grow on the tube surfaces within hours and form slime-like aggregations of millions of pathogenic cells as a biofilm. ...
N8 Medical’s CeraShield™ technology is broadly applicable to nearly all medical devices at risk for biofilm fouling, including endotracheal tubes, urinary catheters, orthopedic implants and cardiac devices. N8 Medical’s promising endotracheal tube initial clinical study results in the demanding intensive care ...
C. auris is able to attach to indwelling medical devices, such as endotracheal tubes and urinary catheters. To address this important problem, N8 Medical’s first application of CSA-131 is in its drug-eluting CeraShield™ endotracheal tube (ETT). ...